These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 26220290)

  • 21. Vaccination with a Porcine Reproductive and Respiratory Syndrome (PRRS) Modified Live Virus Vaccine Followed by Challenge with PRRS Virus and Porcine Circovirus Type 2 (PCV2) Protects against PRRS but Enhances PCV2 Replication and Pathogenesis Compared to Results for Nonvaccinated Cochallenged Controls.
    Niederwerder MC; Bawa B; Serão NV; Trible BR; Kerrigan MA; Lunney JK; Dekkers JC; Rowland RR
    Clin Vaccine Immunol; 2015 Dec; 22(12):1244-54. PubMed ID: 26446422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of a reformulated inactivated chimeric PCV1-2 vaccine based on clinical, virological, pathological and immunological examination under field conditions.
    Seo HW; Han K; Oh Y; Park C; Chae C
    Vaccine; 2012 Oct; 30(47):6671-7. PubMed ID: 22963801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and future prospects of commercially available and experimental vaccines against porcine circovirus type 2 (PCV2).
    Beach NM; Meng XJ
    Virus Res; 2012 Mar; 164(1-2):33-42. PubMed ID: 22005075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a porcine circovirus type 2a (PCV2a) vaccine efficacy against experimental PCV2a, PCV2b, and PCV2d challenge.
    Park KH; Oh T; Yang S; Cho H; Kang I; Chae C
    Vet Microbiol; 2019 Apr; 231():87-92. PubMed ID: 30955830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of sow and/or piglet vaccination of 3 commercial porcine circovirus type 2 (PCV2) single-dose vaccines on pigs under experimental PCV2 challenge.
    Oh Y; Seo HW; Park C; Chae C
    Vet Microbiol; 2014 Aug; 172(3-4):371-80. PubMed ID: 24970364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical, virological, immunological and pathological evaluation of four porcine circovirus type 2 vaccines.
    Seo HW; Han K; Park C; Chae C
    Vet J; 2014 Apr; 200(1):65-70. PubMed ID: 24618398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of cell-mediated immune responses against porcine circovirus type 2 (PCV2) Cap and Rep proteins after vaccination with a commercial PCV2 sub-unit vaccine.
    Fort M; Sibila M; Nofrarías M; Pérez-Martín E; Olvera A; Mateu E; Segalés J
    Vet Immunol Immunopathol; 2012 Nov; 150(1-2):128-32. PubMed ID: 23010221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective immunity in swine induced by Porcine Circovirus 2b inactivated vaccines with different antigen payload.
    Guarneri F; Tresoldi ET; Sarli G; Boniotti MB; Lelli D; Barbieri I; Bacci B; D'Annunzio G; Amadori M
    Vet Microbiol; 2021 Jan; 252():108887. PubMed ID: 33276254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Porcine circovirus type 2 infection decreases the efficacy of a modified live porcine reproductive and respiratory syndrome virus vaccine.
    Opriessnig T; McKeown NE; Harmon KL; Meng XJ; Halbur PG
    Clin Vaccine Immunol; 2006 Aug; 13(8):923-9. PubMed ID: 16893993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of three commercial one-dose porcine circovirus type 2 (PCV2) vaccines in a herd with concurrent circulation of PCV2b and mutant PCV2b.
    Jeong J; Park C; Choi K; Chae C
    Vet Microbiol; 2015 May; 177(1-2):43-52. PubMed ID: 25790733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets.
    Zhang H; Qian P; Peng B; Shi L; Chen H; Li X
    Vaccine; 2015 May; 33(21):2449-56. PubMed ID: 25863115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Capsid proteins from PCV2a genotype confer greater protection against a PCV2b strain than those from PCV2b genotype in pigs: evidence for PCV2b strains becoming more predominant than PCV2a strains from 2000 to 2010s.
    Huang L; Wang Y; Wei Y; Chen D; Liu D; Du W; Xia D; Wu H; Feng L; Liu C
    Appl Microbiol Biotechnol; 2016 Jul; 100(13):5933-43. PubMed ID: 27020283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Porcine circovirus type 2a or 2b based experimental vaccines provide protection against PCV2d/porcine parvovirus 2 co-challenge.
    Opriessnig T; Karuppannan AK; Halbur PG; Calvert JG; Nitzel GP; Matzinger SR; Meng XJ
    Vaccine; 2020 Feb; 38(8):1975-1981. PubMed ID: 31974016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attenuation of porcine circovirus type-2b by replacement with the Rep gene of porcine circovirus type-1.
    Hua T; Wang X; Bai J; Zhang L; Liu J; Jiang P
    Virus Res; 2013 May; 173(2):270-9. PubMed ID: 23454919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlates of Protection Following Vaccination with Inactivated Porcine Circovirus 2 Vaccines.
    Zanotti C; Martinelli N; Lelli D; Amadori M
    Viral Immunol; 2015 Dec; 28(10):600-8. PubMed ID: 26401584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy in pigs of a new inactivated vaccine combining porcine circovirus type 2 and Mycoplasma hyorhinis.
    Wei YW; Zhu HZ; Huang LP; Xia DL; Wu HL; Bian HQ; Feng L; Liu CM
    Vet Microbiol; 2020 Mar; 242():108588. PubMed ID: 32122592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of a new bivalent vaccine of porcine circovirus type 2 and Mycoplasma hyopneumoniae (Fostera™ PCV MH) under experimental conditions.
    Park C; Jeong J; Choi K; Chae C
    Vaccine; 2016 Jan; 34(2):270-275. PubMed ID: 26626212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A commercial vaccine based on PCV2a and an experimental vaccine based on a variant mPCV2b are both effective in protecting pigs against challenge with a 2013 U.S. variant mPCV2b strain.
    Opriessnig T; Gerber PF; Xiao CT; Mogler M; Halbur PG
    Vaccine; 2014 Jan; 32(2):230-7. PubMed ID: 24269319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative analyses of humoral and cell-mediated immune responses upon vaccination with different commercially available single-dose porcine circovirus type 2 vaccines.
    Seo HW; Lee J; Han K; Park C; Chae C
    Res Vet Sci; 2014 Aug; 97(1):38-42. PubMed ID: 24794246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral application of freeze-dried yeast particles expressing the PCV2b Cap protein on their surface induce protection to subsequent PCV2b challenge in vivo.
    Patterson R; Eley T; Browne C; Martineau HM; Werling D
    Vaccine; 2015 Nov; 33(46):6199-205. PubMed ID: 26476879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.